Biotechnology News and Research RSS Feed - Biotechnology News and Research

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

Oncolytic virotherapy medicine shows positive treatment outcomes in late-stage cancer patients

The surprisingly positive treatment outcomes using Rigvir virotherapy for late stages cancer patients were recently published. [More]
Study shows striking differences in white matter volume between obese individuals and lean people

Study shows striking differences in white matter volume between obese individuals and lean people

From middle-age, the brains of obese individuals display differences in white matter similar to those in lean individuals ten years their senior, according to new research led by the University of Cambridge. [More]
Scientists engineer therapeutic system with two arms to get better hold on cancer target

Scientists engineer therapeutic system with two arms to get better hold on cancer target

Scientists have engineered a sort of biological barbell that can get inside cancer cells and do damage to two proteins that work independently and together to enable cancer's survival and spread. [More]
Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS

Next-generation sequencing to evaluate cell-free DNA yields more accurate results in diagnosis of MDS

Using next-generation sequencing (NGS) methods to analyze cell-free DNA in the blood of patients with myelodysplastic syndrome (MDS) yields more accurate results than the current standard approach of Sanger sequencing. [More]
Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad expands product line by launching two human recombinant antigens

Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products, today announced the launch of two human recombinant antigens, expanding the company's portfolio of Critical Raw Materials for the in vitro diagnostics market. [More]
Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health appoints JoyingBio as distributor of PCRD lateral flow immunoassays in China

Abingdon Health Ltd is pleased to announce the appointment of JoyingBio as distributor in China for PCRD nucleic acid lateral flow immunoassays (NALFIA). [More]
Scientists use Regeneration Intelligence to assess perturbation status of many signaling pathways

Scientists use Regeneration Intelligence to assess perturbation status of many signaling pathways

Insilico Medicine, Inc in collaboration with scientists from Atlas Regeneration, Inc, Vision Genomics, Inc and Howard University published two research papers on fibrosis in the lung and liver and fibrotic signatures in glaucoma. [More]
VALIDATE D-Dimer kit from LGC Maine Standards receives US FDA approval for use on hemostasis test systems

VALIDATE D-Dimer kit from LGC Maine Standards receives US FDA approval for use on hemostasis test systems

LGC Maine Standards is pleased to announce our VALIDATE D-Dimer calibration verification / linearity test kit has received US FDA 510(k) clearance for use on Instrument Laboratory ACL TOP hemostasis test systems. [More]
Roche announces FDA approval of  new VENTANA PD-L1 assay

Roche announces FDA approval of new VENTANA PD-L1 assay

Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC). [More]
Advanced Instruments launches novel GloCyte System at 68th AACC Annual Scientific Meeting

Advanced Instruments launches novel GloCyte System at 68th AACC Annual Scientific Meeting

Advanced Instruments, Inc., a leader in laboratory instrumentation, launches their GloCyte Automated Cell Counter System at the 68th AACC Annual Scientific Meeting & Clinical Lab Expo in Philadelphia, PA July 31-August 4. [More]
New gene therapy shows promising results for treating neurodegenerative disorders

New gene therapy shows promising results for treating neurodegenerative disorders

A new gene therapy approach designed to replace the enzyme that is deficient in patients with the inherited neurodegenerative disorders Tay-Sachs and Sandhoff diseases successfully delivered the therapeutic gene to the brains of treated mice, restored enzyme function, and extended survival by about 2.5-fold. [More]
Researchers find promising new therapy for both pediatric and adult cancers

Researchers find promising new therapy for both pediatric and adult cancers

A study conducted at Nationwide Children's Hospital has found that a new chemotherapy is effective against both pediatric and adult cancers, and that it allows other chemotherapies to more readily reach their targets. [More]
Waterloo researchers unveil new screening tool and data at 2016 AAIC

Waterloo researchers unveil new screening tool and data at 2016 AAIC

Two studies involving University of Waterloo researchers presented this week at the 2016 Alzheimer's Association International Conference (AAIC) in Toronto highlight a new diagnostic tool that can identify Alzheimer's disease long before the onset of symptoms as well as the increasing prevalence of Alzheimer's disease in Ontario. [More]
MIT researchers develop novel method for multiscale imaging of the brain tissue

MIT researchers develop novel method for multiscale imaging of the brain tissue

MIT researchers have developed a new technique for imaging brain tissue at multiple scales, allowing them to peer at molecules within cells or take a wider view of the long-range connections between neurons. [More]
Researchers develop new microneedle system to painlessly monitor drugs in bloodstream

Researchers develop new microneedle system to painlessly monitor drugs in bloodstream

Researchers at the University of British Columbia and the Paul Scherrer Institut in Switzerland have created a microneedle drug monitoring system that could one day replace costly, invasive blood draws and improve patient comfort. [More]

Macroecological approach could help predict emergence of new infectious diseases

Ecologists at the University of Georgia are leading a global effort to predict where new infectious diseases are likely to emerge. In a paper published in Ecology Letters, they describe how macroecology—the study of ecological patterns and processes across broad scales of time and space—can provide valuable insights about disease. [More]
Advanced Instruments receives FDA approval to market GloCyte System

Advanced Instruments receives FDA approval to market GloCyte System

Advanced Instruments, Inc., a leader in laboratory instrumentation, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its GloCyte Automated Cell Counter System and GloCyte Low and High Level Controls. [More]
New study reports strains of chimpanzee-carried SIVs can infect human cells

New study reports strains of chimpanzee-carried SIVs can infect human cells

No one knows exactly how it happened. It may have entered through a cut or bite wound, the blood of a chimpanzee seeping into an exposed fingertip or forearm or foot. [More]
Shared lifestyle and environment may contribute to risk of common diseases in families, study shows

Shared lifestyle and environment may contribute to risk of common diseases in families, study shows

Family history of disease may be as much the result of shared lifestyle and surroundings as inherited genes, research has shown. [More]
Study highlights effectiveness of atypical antipsychotic drug in treating children with TD

Study highlights effectiveness of atypical antipsychotic drug in treating children with TD

A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group. [More]
Advertisement
Advertisement